Cite
HARVARD Citation
Tesfamariam, Y. et al. (2019). Adjuvant bisphosphonates or RANK-ligand inhibitors for patients with breast cancer and bone metastases: A systematic review and network meta-analysis. Critical reviews in oncology/hematology. pp. 1-8. [Online].